# High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients

> **NCT06110390** · NA · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 450 (estimated)

## Conditions studied

- Intensive Care
- Airway Extubation
- Critical Care
- Oxygen Therapy

## Interventions

- **DEVICE:** High flow nasal oxygen

## Key facts

- **NCT ID:** NCT06110390
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-17
- **Primary completion:** 2023-12
- **Final completion:** 2024-02
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06110390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06110390, "High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06110390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*